Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-30

Clinical Trial Update: Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of methylene blue for the treatment of severe septic shock and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Septic Shock, Methylene Blue | NA | Status: RECRUITING